Zoll Medical Corporation, which received FDA clearance a few years ago for both home and hospital versions of its wearable defibrillator LifeVest, is now dealing with a range of lawsuits and FDA ...

Despite high overall use of contemporary GDMT, incidences of appropriate LifeVest treatments were high in both NICM and MI/CAD patients: 6.53 appropriate treatments per 100 patient-years in NICM ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT ZOLL®, an Asahi ...